SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-12-01 13:35
Tx date 2022-11-30 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-471.00
-47,100 vol
$0.01 each 		104,181
Filed 2022-06-08 23:52
Tx date 2021-02-16 		$CURE
Biocure Technology Inc. 		Joh, Danny
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$75,000
+250,000 vol
$0.30 each 		250,000
Filed 2022-06-08 23:39
Tx date 2019-03-13 		$CURE
Biocure Technology Inc. 		Joh, Danny
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-08-27 15:51
Tx date 2021-07-21 		$CURE
Biocure Technology Inc. 		Cochlovius, Bjorn
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$75,000
+250,000 vol
$0.30 each 		250,000
Filed 2021-08-27 15:44
Tx date 2021-08-26 		$CURE
Biocure Technology Inc. 		Cochlovius, Bjorn
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-07-22 19:10
Tx date 2021-07-21 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+250,000 vol 		850,000
Filed 2021-07-20 13:47
Tx date 2020-10-15 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants Warrants
16 - Acquisition or disposition under a prospectus exemption 		$7,560
+36,000 vol
$0.21 each 		36,000
Filed 2021-07-20 13:42
Tx date 2018-03-01 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-07-16 18:30
Tx date 2020-10-15 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$5,040
+36,000 vol
$0.14 each 		115,281
Filed 2021-07-16 18:28
Tx date 2020-01-02 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$14,999
+68,181 vol
$0.22 each 		79,281
Filed 2021-07-16 18:12
Tx date 2021-02-16 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$135,000
+450,000 vol
$0.30 each 		450,000
Filed 2021-07-16 18:11
Tx date 2021-01-01 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-114,000
-300,000 vol
$0.38 each 		0
Filed 2021-07-16 18:09
Tx date 2021-02-16 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-114,000
-300,000 vol
$0.38 each
Filed 2021-03-31 01:27
Tx date 2021-02-11 		$CURE
Biocure Technology Inc. 		Ünal, Berkan
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		112,000
Filed 2021-03-31 01:19
Tx date 2021-02-16 		$CURE
Biocure Technology Inc. 		Ünal, Berkan
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$75,000
+250,000 vol
$0.30 each 		350,000
Filed 2021-03-31 01:16
Tx date 2021-02-11 		$CURE
Biocure Technology Inc. 		Ünal, Berkan
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		100,000
Filed 2021-03-31 01:10
Tx date 2021-02-11 		$CURE
Biocure Technology Inc. 		Ünal, Berkan
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		112,000
Filed 2021-02-18 19:12
Tx date 2020-10-16 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Warrants
53 - Grant of warrants 		$7,526
+35,839 vol
$0.21 each 		35,839
Filed 2021-02-18 18:47
Tx date 2017-06-21 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-18 17:40
Tx date 2020-10-16 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
53 - Grant of warrants 		$7,526
+35,839 vol
$0.21 each
Filed 2020-10-21 13:59
Tx date 2020-10-16 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
53 - Grant of warrants 		$7,526
+35,839 vol
$0.21 each
Filed 2021-02-17 21:03
Tx date 2021-02-16 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options 		$300,000
+1,000,000 vol
$0.30 each 		1,035,839
Filed 2021-02-17 21:00
Tx date 2021-01-04 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options
-900,000 vol 		35,839
Filed 2021-02-17 15:38
Tx date 2021-02-16 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$180,000
+600,000 vol
$0.30 each 		600,000
Filed 2021-02-17 15:34
Tx date 2021-01-04 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-480,000 vol 		0
Filed 2020-10-21 13:59
Tx date 2020-10-16 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
53 - Grant of warrants 		$7,526
+35,839 vol
$0.21 each 		935,839
Filed 2020-10-21 13:46
Tx date 2020-10-16 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$5,017
+35,839 vol
$0.14 each 		27,317,506
Filed 2020-10-21 09:22
Tx date 2020-10-16 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$5,040
+36,000 vol
$0.14 each 		47,100
Filed 2020-10-20 13:16
Tx date 2020-10-16 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$5,017
+35,839 vol
$0.14 each
Filed 2020-10-20 15:02
Tx date 2020-10-16 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Holder: JNS Global Energy Inc. (Indirect Ownership)
Options
53 - Grant of warrants 		$7,560
+36,000 vol
$0.21 each 		36,000
Filed 2020-10-20 14:56
Tx date 2015-08-28 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Holder: JNS Global Energy Inc. (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-20 14:54
Tx date 2020-10-16 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Holder: JNS Global Energy Inc. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$5,040
+36,000 vol
$0.14 each 		104,181
Filed 2020-10-20 14:47
Tx date 2020-10-16 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Holder: JNS Global Energy Inc. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$5,040
+36,000 vol
$0.14 each
Filed 2020-10-20 13:16
Tx date 2020-10-16 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$5,017
+35,839 vol
$0.14 each 		27,317,506
Filed 2020-10-14 16:16
Tx date 2019-03-08 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options
-600,000 vol 		0
Filed 2020-10-14 15:56
Tx date 2019-03-08 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options
+600,000 vol
Filed 2020-10-14 15:56
Tx date 2019-03-08 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options
+600,000 vol 		1,200,000
Filed 2020-10-14 15:48
Tx date 2019-04-12 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+480,000 vol 		480,000
Filed 2020-10-14 15:43
Tx date 2019-03-08 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-240,000 vol 		0
Filed 2020-10-14 15:38
Tx date 2019-04-12 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
+900,000 vol 		2,100,000
Filed 2020-01-06 00:50
Tx date 2020-01-03 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Holder: JNS Global Energy Inc. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$14,999
+68,181 vol
$0.22 each 		68,181
Filed 2020-01-06 00:47
Tx date 2015-08-28 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Holder: JNS Global Energy Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-01 15:30
Tx date 2019-10-30 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$-4,773
-11,100 vol
$0.43 each 		11,100
Filed 2019-04-16 13:09
Tx date 2019-03-07 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$136,250
+125,000 vol
$1.09 each
Filed 2019-04-16 13:08
Tx date 2018-03-01 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$127,500
+125,000 vol
$1.02 each
Filed 2019-04-16 13:07
Tx date 2019-03-07 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$136,250
+125,000 vol
$1.09 each
Filed 2019-04-16 13:06
Tx date 2019-04-12 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$114,000
+300,000 vol
$0.38 each 		300,000
Filed 2018-03-27 20:25
Tx date 2018-03-01 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$127,500
+125,000 vol
$1.02 each
Filed 2019-03-15
Tx date 2019-03-13 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-3,000 vol 		196,723
Filed 2018-12-05
Tx date 2018-12-01 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$9,990
+22,200 vol
$0.45 each 		22,200
Filed 2018-12-05
Tx date 2018-03-01 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-12-05
Tx date 2018-12-01 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
-22,200 vol 		199,723
Filed 2018-11-26
Tx date 2018-11-24 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-127,800 vol 		240,000
Filed 2018-11-26
Tx date 2018-11-23 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$28,880
+72,200 vol
$0.40 each 		221,923
Filed 2018-11-26
Tx date 2018-11-23 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-72,200 vol 		367,800
Filed 2018-09-25
Tx date 2018-09-24 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-4,000 vol 		149,723
Filed 2018-09-19
Tx date 2018-04-01 		$CURE
Biocure Technology Inc. 		Nonni, Mark
1 - Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		264,000
Filed 2018-09-07
Tx date 2018-08-27 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-2,000 vol
Filed 2018-09-07
Tx date 2018-08-27 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-2,000 vol 		162,223
Filed 2018-09-07
Tx date 2018-09-07 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-8,500 vol 		153,723
Filed 2018-08-29
Tx date 2018-08-27 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-2,000 vol 		162,223
Filed 2018-08-24
Tx date 2018-08-23 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-6,500 vol 		165,723
Filed 2018-08-24
Tx date 2018-08-24 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-1,500 vol 		164,223
Filed 2018-08-14
Tx date 2018-08-13 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-5,500 vol 		172,223
Filed 2018-08-10
Tx date 2018-08-09 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-500 vol 		189,223
Filed 2018-08-10
Tx date 2018-08-08 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$32,000
+80,000 vol
$0.40 each 		189,723
Filed 2018-08-10
Tx date 2018-08-10 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-11,500 vol 		177,723
Filed 2018-08-10
Tx date 2018-08-08 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-80,000 vol 		440,000
Filed 2018-08-07
Tx date 2018-08-07 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-4,000 vol 		109,723
Filed 2018-08-07
Tx date 2018-08-03 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-16,000 vol 		113,723
Filed 2018-07-31
Tx date 2018-07-30 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-10,000 vol 		129,723
Filed 2018-07-20
Tx date 2018-07-19 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-10,000 vol 		139,723
Filed 2018-07-06
Tx date 2018-07-05 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-100,000 vol 		520,000
Filed 2018-07-06
Tx date 2018-07-06 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-5,000 vol 		149,723
Filed 2018-07-06
Tx date 2018-07-05 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$40,000
+100,000 vol
$0.40 each 		154,723
Filed 2018-07-05
Tx date 2018-07-05 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-15,000 vol 		54,723
Filed 2018-07-03
Tx date 2018-07-03 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-30,800
-38,500 vol
$0.80 each 		69,723
Filed 2018-06-25
Tx date 2018-06-22 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,600
-2,000 vol
$0.80 each 		108,223
Filed 2018-06-19
Tx date 2018-06-15 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-7,600
-9,500 vol
$0.80 each 		110,223
Filed 2018-06-19
Tx date 2018-06-15 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-6,800
-8,500 vol
$0.80 each
Filed 2018-06-18
Tx date 2018-06-15 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-6,800
-8,500 vol
$0.80 each 		111,223
Filed 2018-04-16
Tx date 2018-04-11 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
+600,000 vol 		600,000
Filed 2018-04-16
Tx date 2018-04-11 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
+600,000 vol
Filed 2018-04-16
Tx date 2017-06-21 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-16
Tx date 2017-06-21 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-13
Tx date 2018-04-11 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$165,600
+240,000 vol
$0.69 each
Filed 2018-04-13
Tx date 2018-04-11 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+240,000 vol 		620,000
Filed 2018-03-27
Tx date 2018-03-01 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$127,500
+125,000 vol
$1.02 each 		125,000
Filed 2018-03-27
Tx date 2018-03-01 		$CURE
Biocure Technology Inc. 		Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-02-21
Tx date 2018-02-21 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-20,000
-50,000 vol
$0.40 each 		380,000
Filed 2018-02-21
Tx date 2018-02-21 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$20,000
+50,000 vol
$0.40 each 		119,723
Filed 2018-02-17
Tx date 2018-02-16 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-20,000
-50,000 vol
$0.40 each 		430,000
Filed 2018-02-17
Tx date 2017-11-24 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+480,000 vol 		480,000
Filed 2018-02-17
Tx date 2017-11-24 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+480,000 vol
Filed 2018-02-17
Tx date 2015-08-28 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-02-17
Tx date 2018-02-16 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$20,000
+50,000 vol
$0.40 each 		69,723
Filed 2018-02-07
Tx date 2018-02-06 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-15,500
-10,000 vol
$1.55 each 		19,723
Filed 2018-02-01
Tx date 2017-11-30 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-250,277 vol 		49,723
Filed 2018-02-01
Tx date 2017-11-30 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-250,278 vol
Filed 2018-02-01
Tx date 2018-02-01 		$CURE
Biocure Technology Inc. 		Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-29,000
-20,000 vol
$1.45 each 		29,723
Filed 2017-11-28
Tx date 2017-11-24 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+25,090,272 vol 		27,281,667
Filed 2017-11-28
Tx date 2017-11-24 		$CURE
Biocure Technology Inc. 		LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
37 - Stock split or consolidation
-11,030,342 vol 		2,191,395